Public recall detail

CandiZYME (2013-10-20)

medium
Recall Safety notice
Quick summary

Quick summary: CandiZYME (2013-10-20) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: CandiZYME (2013-10-20) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionCandiZYME DIN, NPN, DIN-HIM NPN 80036437 Dosage form Capsules Strength 1,3-beta-D-xylan xylanohydrolase 37.5 mg 15000.0 FCC HCU 1,4-alpha-D-Glucan glucohydrolase 50.0 FCC AGU 50.0 mg 4-(1,3;1,4)-beta-D-Glucan 4-glucanohydrolase 250.0 mg 37500.0 FCC CU 4-alpha-D-Glucan glucanohydrolase 60.0 mg 6000.0 FCC DU Beta-galactosidase 2.5 mg 250.0 FCC ALU Malt diastase 12.5 mg 125.0 FCC DP N- Acetylmuramyl hydrolase 7.5 FCC LU 7.5 mg Protease 200.0 mg 100000.0 FCC HUT Triacylglycerol acylhydrolase 6.5 mg 500.0 FCC LU beta-D-fructofuranoside fructohydrolase 3.5 mg 350.0 FCC SU Lot or serial number 2526300 Companies Recalling Firm Renew Life Canada 8-1273 North Service Road Oakville L6H 1A7 Ontario CANADA Marketing Authorization Holder Renew Life Canada 8-1273 North Service Road Oakville L6H 1A7 Ontario CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...